logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
  • alpha-Adrenergic Agonist class drugs

    FiltersReset Filters
    26 results
    • adrenalin

      (epinephrine)
      Par Pharmaceutical, Inc.
      Usage: This drug is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from various triggers and exercise-induced anaphylaxis. It is also used to increase mean arterial blood pressure in adults with hypotension associated with septic shock.
    • adrenalin

      (epinephrine)
      Par Pharmaceutical, Inc.
      Usage: This drug is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis due to various allergens and idiopathic or exercise-induced anaphylaxis. It is also used to increase mean arterial blood pressure in adults with hypotension associated with septic shock.
    • adrenalin

      (epinephrine)
      ENDO USA, Inc.
      Usage: This drug is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis due to various allergens. It is also used to increase mean arterial blood pressure in adults with hypotension associated with septic shock.
    • alphagan p

      (brimonidine tartrate)
      Allergan, Inc.
      Usage: ALPHAGAN P (brimonidine tartrate ophthalmic solution) is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
    • auvi-q

      (epinephrine)
      kaleo, Inc
      Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis due to insect stings, food, medications, and other allergens. It is intended for immediate self-administration in individuals at risk for anaphylaxis and is not a substitute for medical care.
    • brimonidine

      (brimonidine tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution is an alpha adrenergic receptor agonist used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
    • brimonidine tartrate

      (Brimonidine Tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution, 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Its effectiveness may diminish over time, necessitating close monitoring of IOP in patients.
    • brimonidine tartrate

      (Brimonidine Tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution, 0.15%, is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
    • brimonidine tartrate and timolol maleate

      (Brimonidine Tartrate and Timolol Maleate)
      Sandoz Inc
      Usage: Brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%/0.5%, is indicated for reducing elevated intraocular pressure in patients with glaucoma or ocular hypertension, serving as adjunctive or replacement therapy when IOP is inadequately controlled.
    • brimonidine tartrate/timolol maleate

      (Brimonidine Tartrate and Timolol Maleate)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Brimonidine tartrate/timolol maleate ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with glaucoma or ocular hypertension, serving as adjunctive or replacement therapy for those with inadequately controlled pressure. It is administered twice daily.